CDKN2A and soft tissue sarcoma: In mice, genetic modification of the germline melanoma susceptibility gene Cdkn2a (p16Ink4a null mice) does not result in melanoma, with these mice typically developing soft‐tissue sarcomas and lymphomas 45.